Skip to main content
< Back
About
About the conference
App
Organisers & Partners
Latest updates
Press room
Registration
Call for abstracts
Programme
Tracks
Speakers
Side events
Venue
About the venue
Rooms
Subscribe
days
hours
minutes
seconds
Oral presentation session
Sessions
Wednesday, 23 November
10:50
Advances in toxicology
10:50
to
12:20
Central square 2 (C2)
Ilkka Ojanperä
Commonalities across addictions
10:50
to
12:20
Insights zone 2 (I2)
Samuel Tomczyk
COVID-19 implications for services and responses
10:50
to
12:20
Central square 3 (C3)
Margarida Gaspar de Matos
Drug treatment
10:50
to
12:20
Knowledge market 3 (K3)
Alison Ritter
Gambling Research
10:50
to
12:20
Insights zone 3 (I3)
Luke Clark
13:20
e-/m-health interventions for substance use disorders
13:20
to
14:50
Central square 3 (C3)
Peter J. Adams
Gambling epidemiology and new trends
13:20
to
14:50
Insights zone 3 (I3)
Elisa Benedetti,
Annie-claude Savard
Hepatitis C epidemiology and prevention
13:20
to
14:50
Knowledge market 3 (K3)
Stine Hoj
15:00
Alcohol use and AUD during COVID-19 pandemic
15:00
to
16:30
Central square 1 (C1)
Benjamin Rolland
Estimating harm
15:00
to
16:30
Central square 3 (C3)
Xavier Majó Roca
Estimating prevalence
15:00
to
16:30
Knowledge market 4 (K4)
Catherine Comiskey
Injecting-related infections and drug surveillance
15:00
to
16:30
Knowledge market 3 (K3)
Adelina Artenie
16:50
Alcohol use disorder treatment and its epidemiology
16:50
to
18:20
Central square 1 (C1)
Karl Mann
Drugs and community
16:50
to
18:20
Insights zone 2 (I2)
Rachele Donini
EU4MD Treatment facility survey
16:50
to
18:20
Networking zone 2 (N2)
Viktor Mravcik,
Anne Bergenstrom
Focusing on gender issues
16:50
to
18:20
Central square 3 (C3)
Minerva-Melpomeni Malliori
Thursday, 24 November
09:00
Contemporary Issues
09:00
to
10:30
Central square 2 (C2)
Anne Line Bretteville-Jensen
10:50
Alcohol policies
10:50
to
12:20
Central square 1 (C1)
Geert Dom
Neurology and neuropsychology
10:50
to
12:20
Central square 3 (C3)
Teresa Summavielle
Online and social identities
10:50
to
12:20
Insights zone 2 (I2)
Peer van der Kreeft
Practitioners informing practice
10:50
to
12:20
Knowledge market 3 (K3)
Gerhard Buhringer
Problematic internet and videogame use
10:50
to
12:20
Insights zone 3 (I3)
Sabrina Molinaro
Substance use and trauma
10:50
to
12:20
Knowledge market 2 (K2)
Sarah Welch
13:20
Childhood risk factors in substance use and mental health
13:20
to
14:50
Knowledge market 2 (K2)
Richard Pates
Hepatitis C testing and treatment
13:20
to
14:50
Knowledge market 3 (K3)
Julie Bruneau,
Jason Grebely
New Psychoactive Substances
13:20
to
14:50
Insights zone 4 (I4)
Katarzyna Berkowicz
Novel approaches of alcohol use disorder
13:20
to
14:50
Central square 1 (C1)
Gerardo Flórez
Smoking and e-cigarettes
13:20
to
14:50
Central square 3 (C3)
John Marsden
Understanding problematic gambling
13:20
to
14:50
Insights zone 3 (I3)
Antonius Van Rooij
15:00
Client-centered approaches
15:00
to
16:30
Central square 3 (C3)
Katrin Schiffer
Models to improve the health of people who inject drugs
15:00
to
16:30
Knowledge market 3 (K3)
Jonas Demant,
Rose Schmidt
Preventions interventions
15:00
to
16:30
Insights zone 2 (I2)
Ina Koning
Substance use and mental health during COVID-19
15:00
to
16:30
Knowledge market 2 (K2)
John Strang
16:50
Innovative approaches to tackling the drug overdoses
16:50
to
18:20
Knowledge market 1 (K1)
Alex Stevens
Insights from treatment I
16:50
to
18:20
Central square 3 (C3)
Mayyada Wazaify
New frontiers to regulating cannabis for public health and social justice
16:50
to
18:20
Insights zone 2 (I2)
Simon Lenton
Trajectories of cannabis use during periods of policy change
16:50
to
18:20
Central square 2 (C2)
Rosalie Pacula
Young people, substance use and prevention
16:50
to
18:20
Knowledge market 3 (K3)
Fabrizio Faggiano
Friday, 25 November
09:00
Insights from treatment II
09:00
to
10:30
Central square 2 (C2)
Graça Vilar
10:50
Gambling, policies and interventions
10:50
to
12:20
Insights zone 3 (I3)
Steve Sharman,
Anouk Tuijnman
Harm reduction or prevention?
10:50
to
12:20
Insights zone 2 (I2)
Gregor Burkhart
Language values and theory in drugs policy reform
10:50
to
12:20
Knowledge market 1 (K1)
Caitlin Hughes
Mortality among people who use drugs
10:50
to
12:20
Knowledge market 3 (K3)
Jack Stone,
Louisa Degenhardt
Recreational drug use and risk
10:50
to
12:20
Central square 3 (C3)
Alberto Oteo
Substance use and prison
10:50
to
12:20
Central square 1 (C1)
Torsten Kolind
Substance use and sexual behaviours
10:50
to
12:20
Knowledge market 4 (K4)
Iciar Indave
13:20
Challenging issues for drug research
13:20
to
14:50
Central square 1 (C1)
Marya Haynes
Changes and trends in how people are buying drugs
13:20
to
14:50
Insights zone 4 (I4)
Ada Beselia,
Anton Gomez-Escolar
Overdose prevention
13:20
to
14:50
Knowledge market 3 (K3)
Andrew McAuley,
Suzanne Nielsen
Substance use, mental health risk and suicide
13:20
to
14:50
Knowledge market 2 (K2)
Sarah Welch
Using innovative data or methods to assess drug markets and drug policy impacts
13:20
to
14:50
Knowledge market 1 (K1)
Tom Decorte
Working with the most vulnerable
13:20
to
14:50
Central square 3 (C3)
Jürgen Rehm